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Slowly growing, scotochromogenic bacteria of a novelMycobacterium species were isolated from
lymph node samples in two children and pulmonary samples in two elderly patients from different
regions in the Netherlands as well as from a surface water sample in Zambia. Its 16S rRNA gene,
16S–23S internal transcribed spacer (ITS), hsp65 and rpoB gene sequences are unique in
comparison with other mycobacteria. Phylogenetic analysis based on the 16S rRNA gene
sequence revealed that these micro-organisms are most closely related to Mycobacterium
scrofulaceum ATCC 19981T (8 differences; 0.6% divergence). The hsp65 sequence shows
96% similarity to that of Mycobacterium saskatchewanense MB54784 and the rpoB sequence
shows 95% similarity to that of Mycobacterium chimaera CIP 107892T. The 16S–23S ITS
sequence places these micro-organisms within theMycobacterium avium complex, as a novel ITS
sequevar. This is not supported by analysis of the 16S rRNA, hsp65 or rpoB gene sequences.
Their scotochromogenicity, combined with mostly positive urease, positive semiquantitative
catalase and negative tellurite reduction tests, set these isolates apart from related species. The
mycolic acid patterns, obtained by HPLC, are similar to that of Mycobacterium scrofulaceum,
though the peak heights and distribution present minor differences. We propose the name
Mycobacterium mantenii sp. nov. for this novel species. The type strain, isolated from a lymph
node biopsy sample, is strain 04-1474T (5NLA000401474T 5CIP 109863T 5DSM 45255T).
Non-tuberculous mycobacteria (NTM) are common in the
environment and can be opportunistic pathogens. The
NTM are capable of causing a wide spectrum of clinical
disease. Pulmonary NTM disease, mostly in patients with
pre-existing chronic pulmonary diseases, is most common,
followed by lymphadenitis in immunocompetent children
and disseminated disease in immunocompromised patients
(Griffith et al., 2007).
Mycobacterium scrofulaceum, first described by Prissick &
Masson (1956), is mainly a causative agent of paediatric
cervicofacial lymphadenitis. The isolation frequency of M.
scrofulaceum has decreased in recent decades, presumably
Abbreviations: ITS, internal transcribed spacer; MAC, Mycobacterium
avium complex; MIC, minimal inhibitory concentration; NTM, non-
tuberculous mycobacteria; TCH, thiophene-2-carboxylic hydrazide.
The GenBank/EMBL/DDBJ accession numbers for the 16S rRNA
gene, 16S–23S ITS, hsp65 and rpoB gene sequences of strains 04-
1474T (5NLA000401474T) and 08-224 (5NLA000800224) are
respectively FJ042897 and FJ232521 (16S rRNA gene), FJ232522
and FJ426335 (16S–23S ITS), FJ232523 and FJ426336 (hsp65) and
FJ232524 and FJ426337 (rpoB).
Phylogenetic trees based on concatenated 16S rRNA, hsp65 and rpoB
gene sequences as well as the 16S–23S ITS of the studied isolates and
related Mycobacterium species are available as supplementary material
with the online version of this paper.
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because of competition with Mycobacterium avium after
chlorination of tap water became more commonplace
(Griffith et al., 2007). On the other hand, several
scotochromogenic, slowly growing mycobacteria isolated
from children with cervicofacial lymphadenitis have been
elevated to separate species status. These may have
previously been falsely identified as M. scrofulaceum
(Tortoli, 2003). The International Working Group on
Mycobacterial Taxonomy also found several isolates related
to, but different from, M. scrofulaceum (Wayne et al.,
1996).
In this paper, we report on a group of five isolates with
unique 16S rRNA gene, 16S–23S internal transcribed
spacer (ITS), hsp65 and rpoB sequences that represent a
novel Mycobacterium species, related to M. scrofulaceum.
The isolates were cultured from four patients, including
two cases of paediatric cervicofacial lymphadenitis, in the
Netherlands and from the Zambezi River, Zambia.
Case reports
In 2004, a previously healthy, 2 K-year-old girl presented
with an 8-week history of right submandibular erythema-
tous swelling, 3 cm in diameter, with obvious fluctuation
and a red skin. She was otherwise asymptomatic. A fine-
needle aspiration from the swelling was performed. The
acid-fast stain of the material obtained was positive. An M.
avium complex (MAC) strain was detected by real-time
PCR, using the 16S–23S ITS as a target, and a scotochro-
mogenic mycobacterium grew in culture (isolate 04-
1474T). Antibiotic therapy with clarithromycin (15 mg
kg21) and rifabutin (5 mg kg21) was started for a 12 week
period. An open wound with persistent drainage developed
and healed during therapy. After 2 years, only a small scar
remained.
The second patient was a previously healthy, 18-month-old
girl who presented at another hospital in the Netherlands
in 2007 with a fluctuating, painless, left-sided, subman-
dibular swelling, 4 cm in diameter, with violaceous
overlying skin. She had no other symptoms. A lymph
node biopsy with drainage was performed and a scoto-
chromogenic mycobacterium was cultured from the biopsy
material (isolate 07-937). Involution of the lymph node
was noted during follow-up; no further therapy was
necessary and after 1 year only a small scar remained.
The third patient was a 92-year-old Dutch woman who was
evaluated by a respiratory physician in a regional hospital
in the north of the Netherlands in 2008. Her medical
history included bronchiectasis. She presented with a
productive cough and slight dyspnoea. A scotochromo-
genic mycobacterium was isolated from one of three
sputum samples (isolate 07-1794). Her symptoms and
radiographic features were not suggestive of mycobacterial
disease, and follow-up cultures remained negative, so this
isolate was not considered clinically relevant, based on the
American Thoracic Society diagnostic criteria (Griffith
et al., 2007).
The fourth patient was a 68-year-old Dutch male who
reported with chronic cough and purulent sputum in 2008.
His medical history included an a-1-antitrypsin deficiency
and resulting pulmonary emphysema. A scotochromogenic
mycobacterium was isolated from a bronchoalveolar lavage
(isolate 08-1102). In the absence of radiographic features
suggestive of pulmonary mycobacterial disease or positive
follow-up cultures, this isolate was also not considered
clinically relevant.
The fifth isolate was cultured from a water sample we took
for other research purposes from the Zambezi river,
Zambia, 150 m upstream from the Victoria Falls in 2007
(isolate 08-224).
All five isolates were subcultured on Middlebrook 7H10
and the egg-based Ogawa and Stonebrink solid media, as
well in the Mycobacterial Growth Indicator Tube (MGIT)
system. All media were incubated at 36 uC; Middlebrook
7H10 slants were also incubated at 25, 30 and 45 uC.
The Inno-LiPA Mycobacteria v2 reverse hybridization test
was used for primary identification, according to the
manufacturer’s instructions. To obtain identification to the
species level, we sequenced the full 16S rRNA gene and the
16S–23S ITS and partially sequenced the hsp65 and rpoB
genes, using previously published approaches (Springer et al.,
1996; Roth et al., 1998; Kim et al., 1999; Telenti et al., 1993).
We compared the sequences obtained with the GenBank/
EMBL sequence database. The full 16S rRNA gene
sequences of the five isolates were aligned with those of
reference strains of the closest related mycobacteria using
CLUSTAL_X software (Thompson et al., 1997). The resulting
topology and tree, inferred by neighbour-joining and
visualized using the MEGA 4.0 software package (Tamura et
al., 2007), were evaluated by bootstrap analyses based on
1000 resamplings (Fig. 1).
For biochemical and phenotypic identification, we inves-
tigated colony morphology, ability to grow at temperatures
ranging from 25 to 45 uC, niacin accumulation, nitrate
reduction, b-glucosidase, Tween 80 hydrolysis, 3-day
arylsulfatase, urease, tellurite reduction, 68 uC and semi-
quantitative catalase, growth rate, pigmentation, growth on
MacConkey agar and tolerance of (mg ml21) thiophene-2-
carboxylic hydrazide (TCH) (5), oleate (250), p-nitroben-
zoic acid (500), thiacetazone (10), hydroxylamine (500)
and isoniazid (1), all in Middlebrook 7H10 agar, following
previously published guidelines (Kent & Kubica, 1985).
HPLC was used to investigate the cell-wall mycolic acid
composition according to methods reported previously
(CDC, 1996). We used the HPLC mycobacterium library
(http://www.MycobacToscana.it) for visual comparisons.
Susceptibility testing was performed using the
Middlebrook 7H10 agar dilution method (van Klingeren
et al., 2007). We tested susceptibility to rifampicin,
rifabutin, isoniazid, ethambutol, streptomycin, amikacin,
clarithromycin, ciprofloxacin, moxifloxacin, cycloserine,
prothionamide, clofazimine and linezolid.
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All five samples yielded small colonies with bright-yellow
pigmentation after 3 weeks of incubation on solid media at
36 uC; growth was slower at 25 and 30 uC and no growth
occurred at 45 uC.
For all five isolates, the Inno-LiPA Mycobacteria v2 reverse
hybridization test revealed a reaction with the ‘M. avium–
intracellulare–scrofulaceum complex’ probe only. The full
16S rRNA gene sequence (1437 bp) revealed eight
differences (99.4% similarity) from the sequence of M.
scrofulaceum ATCC 19981T in all four clinical isolates
(Table 1); the sequence of the Zambezi river isolate had a
single difference from the sequences of the four clinical
isolates and differed at nine positions from the sequence of
M. scrofulaceum ATCC 19981T. All five isolates shared the
3 bp deletion in the hypervariable region B of the 16S
rRNA gene that is typical of M. scrofulaceum and absent
from MAC species.
We recorded identical ITS, hsp65 and rpoB gene sequences
in all four clinical isolates; the results of comparison with
sequences in GenBank are detailed in Table 1. The
sequences of the Zambezi river isolate differed from the
clinical isolates at 11 positions (4%) in the 16S–23S ITS, 3
positions (1%) in hsp65 and 5 positions (2%) in the rpoB
sequence.
Based on the 1437 bp 16S rRNA gene sequence, the five
isolates were most closely related to M. scrofulaceum and
Mycobacterium seoulense (Table 1 and Fig. 1), which also
are scotochromogenic, slowly growing mycobacteria
(Prissick & Masson, 1956; Mun et al., 2007). The hsp65
sequence and, to a lesser extent, the rpoB sequence suggest
that our isolates are related to Mycobacterium saskatch-
ewanense, another scotochromogenic, slowly growing
NTM (Turenne et al., 2004). These observations, as well
as the more distant relationship to the MAC, were
confirmed in phylogenetic trees based on multisequence
alignment of hsp65 gene (Fig. 2) and rpoB gene (Fig. 3)
sequences. In addition, we concatenated the 16S rRNA
gene, hsp65 and rpoB sequences and aligned these with
concatenated sequences of related Mycobacterium species
(Stackebrandt et al., 2002). The resulting tree is available as
Supplementary Fig. S1 in IJSEM Online.
The ITS sequence is most closely related to those of
members of the MAC (Table 1 and Supplementary Fig. S2).
This matches the Inno-LiPA results, which uses the ITS as
Fig. 1. Phylogenetic relationship of strains of
Mycobacterium mantenii sp. nov. and related
species of Mycobacterium, based on 16S
rRNA gene sequences. The neighbour-joining
tree was created, bootstrapped 1000 times
and visualized with MEGA 4.0. Bootstrap values
are indicated at the nodes. Bar, 0.002
substitutions per nucleotide position.
Table 1. Molecular identification results for strain 04-1474T
Target Length (bp) Results of GenBank comparison
Similarity Strain Accession no.
16S rRNA gene 1437 99% (1429/1437) M. scrofulaceum ATCC 19981T AF480604
99% (1422/1439) M. seoulense 03-19T DQ536403
99% (1422/1441) M. avium ATCC 25291T EF521895
98% (1407/1440) M. saskatchewanense 00-250T AY208856
16S–23S ITS 281 96% (271/281) M. vulneris RiVM 9601918 (MAC-Q) AF315833
96% (270/281) MAC strain ATCC 35847 (MAC-E) L07852
96% (269/281) Mycobacterium sp. RiVM 9701605 (MAC-R) AF315834
96% (269/281) MAC strain 5154-O’Connor (MAC-F) L07853
hsp65 424 97% (410/424) M. saskatchewanense MB54784 AY208859
97% (410/424) M. triplex CIP 106108T AF547882
96% (408/424) M. avium ATCC 25291T AY299177
96% (408/424) M. genavense DSM 44424T AF547837
rpoB 301 96% (288/301) M. chimaera CIP 107892T AY943187
96% (288/301) M. intracellulare CIP 104243T AY544930
96% (282/295) M. saskatchewanense 00-250T AY943192
95% (285/301) M. seoulense 03-19T DQ536405
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its target. The different phylogenetic relationships arising
from the different genetic targets, as well as the extent of
the differences, add to our view that these isolates make up
a separate species.
The five studied isolates tested negative for niacin
accumulation, nitrate reduction, b-glucosidase, Tween 80
hydrolysis, tellurite reductase, 3 day arylsulfatase and
growth on MacConkey agar, but tested positive for urease
(3/5), 68 uC catalase and semiquantitative catalase. The
isolates were tolerant of isoniazid, thiacetazone, p-nitro-
benzoic acid, TCH and oleic acid, but not hydroxylamine.
The negative tellurite reduction tests and mixed urease
results set the isolates apart from M. scrofulaceum, M.
saskatchewanense and M. seoulense; our isolates also differ
from the latter in their negative nitrate reduction tests.
Their scotochromogenicity, combined with uniformly
positive semiquantitative and 68 uC catalase tests, mostly
positive urease and negative tellurite reduction tests and
susceptibility to hydroxylamine, set them apart from the
MAC (Table 2).
The HPLC profiles of strain 04-1474T (5NLA000401474T)
and the other clinical isolates are identical and overlap that
typical of the MAC, M. scrofulaceum and M. seoulense, i.e.
three clusters of peaks, one early, large cluster and two late,
smaller clusters (Fig. 4), though the peak heights and
distribution present minor differences. This profile differs
from the single, late-emerging cluster of peaks character-
istic of M. saskatchewanense (Turenne et al., 2004). The
profile of the Zambezi river isolate (isolate 08-224) is
slightly divergent, with different peak heights in the first
and higher peaks in the second cluster (Fig. 4). A divergent
HPLC profile in environmental isolates compared with
clinical isolates has also been noted for Mycobacterium
bohemicum (Torkko et al., 2001).
The clinical isolates were only susceptible in vitro to
rifampicin, rifabutin, clarithromycin, cycloserine, clofazi-
mine and prothionamide; minimal inhibitory concentra-
tions (MICs) are recorded in Table 3. The drug
susceptibility pattern is similar to that of M. scrofulaceum
and the members of the MAC, except for the remarkable in
vitro susceptibility to the rifamycins, i.e. rifampicin and
rifabutin (Table 3).
Although there is a single difference in the 16S rRNA gene
sequence, we consider the Zambezi river isolate and our four
clinical isolates to belong to a single species, based on the
minor genetic differences and overlapping biochemical and
phenotypic features. Microheterogeneity in the 16S rRNA
gene sequence has been described previously in the NTM
(Kirschner & Bo¨ttger, 1992). The slight genetic differences
may reflect the evolutionary divergence among NTM.
The five described isolates make up a novel species,
phylogenetically and phenotypically related to M. scroful-
aceum, M. seoulense, M. saskatchewanense and, albeit more
distantly, the MAC. Biochemical features, however, offer
little distinction in the MAC and HPLC patterns of the
MAC and M. scrofulaceum are known to overlap (Wayne
et al., 1996). The 16S–23S ITS sequence places the five
isolates inside the MAC, although bootstrap levels are low
(Supplementary Fig. S2). This does result in misidentifica-
tion as a MAC species by the Inno-Lipa assay, not unlike
the identification of M. saskatchewanense as MAC by the
Accuprobe assay (Turenne et al., 2004). ITS sequences have
been useful for taxonomic assignment within the MAC
(Frothingham & Wilson, 1993; Tortoli et al., 2004; Murcia
et al., 2006; van Ingen et al., 2009). Our isolates comprise
two distinct MAC ITS sequevars although, for a species not
likely to be part of the MAC, naming them as such would
be misleading.
Fig. 2. Phylogenetic relationship of strains of
M. mantenii sp. nov. and related species of
Mycobacterium, based on hsp65 gene
sequences. See Fig. 1 for further details. Bar,
0.01 substitutions per nucleotide position.
Fig. 3. Phylogenetic relationship of strains of
M. mantenii sp. nov. and related species of
Mycobacterium, based on rpoB gene
sequences. See Fig. 1 for further details. Bar,
0.01 substitutions per nucleotide position.
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The spectrum of human disease of the novel species,
represented by the five described isolates, appears similar to
that of M. scrofulaceum.
Based on all available genetic, phenotypic and clinical data,
we conclude that the five isolates make up a novel NTM
species most closely related to M. scrofulaceum and related
to, but not part of, the MAC.
Description of Mycobacterium mantenii sp. nov.
Mycobacterium mantenii (man.te9ni.i. N.L. gen. masc. n.
mantenii of Manten, in honour of Dr A. Manten,
microbiologist, who published the first cases of NTM
disease in the Netherlands in 1957, as well as landmark
reviews on the clinical relevance of NTM in the
Netherlands).
The bacillus stains acid–alcohol-fast. Cells are short rods,
with frequent coccid forms. No cording, spores or
filaments are present. On Middlebrook 7H10, Ogawa and
Stonebrink media, mature growth develops after 28 days of
incubation at 25–36 uC; no growth occurs at 45 uC.
Colonies are small, smooth, scotochromogenic and yellow.
Table 2. Biochemical features that differentiate the five novel isolates from related species
Reference species: MSC, M. scrofulaceum; MSE, M. seoulense; MSK, M. saskatchewanense; MAV, M. avium. Comparative data were extracted from
Wayne & Kubica (1986), Turenne et al. (2004) and Mun et al. (2007). V, Variable; ND, no data available.
Test 04-1474T 07-937 07-1794 08-224 08-1102 MSC MSE MSK MAV
Nitrate reduction 2 2 2 2 2 2 + 2 2
68 uC catalase + + + + + + + + V
Catalase .45 mm + + + + + + ND V 2
Tellurite reduction 2 2 2 2 2 + V V +
Urease + 2 + 2 + + 2 2 2
Pigmentation* SC SC SC SC SC SC SC SC NC
Growth at 45 uC 2 2 2 2 2 2 2 2 V
Tolerance of hydroxylamineD 2 2 2 2 2 ND ND ND V
*SC, Scotochromogenic; NC, non-chromogenic.
DAt 500 mg ml21 in Middlebrook 7H10 agar.
Fig. 4. Mycolic acid patterns of M. mantenii sp. nov. strains 04-
1474T and 08-224 (Zambezi), M. scrofulaceum and M. avium
obtained by HPLC analysis. One early and one late cluster of
peaks are present in all four profiles, although the peak heights and
distribution are different. The Zambezi isolate is divergent, with a
different peak distribution in the first cluster and a pronounced
second cluster. HMMIS, High-molecular-mass internal standard.
Table 3. Minimum inhibitory concentrations (mg ml”1) by the
agar dilution method
Agent 04-1474T 07-937 07-1794 08-1102
Isoniazid .2 .2 .2 .2
Rifampicin 1 1 1 1
Ethambutol 10 20 10 5–10
Streptomycin 20 20 10 5
Rifabutin ¡0.2 ¡0.2 ¡0.2 ¡0.2
Amikacin 20 .20 10 10
Ciprofloxacin 16 .16 16 16
Clarithromycin ¡2 8 4 4
Cycloserine 20 50 10 10
Clofazimine ¡0.5 5 ¡0.5 ¡0.5
Prothionamide 5 5 5 .20
Moxifloxacin .2 .2 .2 .2
Linezolid .2 .2 .2 .2
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Negative for niacin accumulation, nitrate reduction, b-
glucosidase, Tween 80 hydrolysis, tellurite reduction, 3 day
arylsulfatase and growth on MacConkey agar, but positive
for urease, 68 uC catalase and semiquantitative catalase. It
is tolerant of isoniazid, thiacetazone, p-nitrobenzoic acid,
TCH and oleic acid, but not hydroxylamine. Readily
identifiable by its unique 16S rRNA gene, 16S–23S ITS,
hsp65 and rpoB gene sequences.
The type strain, recovered from a lymph node biopsy
specimen, is strain 04-1474T (5NLA000401474T 5CIP
109863T 5DSM 45255T).
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